BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29070975)

  • 1. Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer.
    Padayachee ER; Biteghe FAN; Malindi Z; Bauerschlag D; Barth S
    Transfus Med Hemother; 2017 Sep; 44(5):303-310. PubMed ID: 29070975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of SNAP-tag technology in skin cancer therapy.
    Padayachee ER; Adeola HA; Van Wyk JC; Nsole Biteghe FA; Chetty S; Khumalo NP; Barth S
    Health Sci Rep; 2019 Feb; 2(2):e103. PubMed ID: 30809593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
    Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
    Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells.
    Woitok M; Klose D; Di Fiore S; Richter W; Stein C; Gresch G; Grieger E; Barth S; Fischer R; Kolberg K; Niesen J
    Onco Targets Ther; 2017; 10():3313-3327. PubMed ID: 28740407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
    Mungra N; Biteghe FAN; Malindi Z; Huysamen AM; Karaan M; Hardcastle NS; Bunjun R; Chetty S; Naran K; Lang D; Richter W; Hunter R; Barth S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12203-12225. PubMed ID: 37432459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology.
    Hussain AF; Heppenstall PA; Kampmeier F; Meinhold-Heerlein I; Barth S
    Nat Protoc; 2019 Nov; 14(11):3101-3125. PubMed ID: 31605098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment.
    Zhang C; Sheng W; Al-Rawe M; Mohiuddin TM; Niebert M; Zeppernick F; Meihold-Heerlein I; Hussain AF
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.
    Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S
    Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas.
    Zhang L; Fang Y; Kopeček J; Yang J
    Eur J Pharm Sci; 2017 May; 103():36-46. PubMed ID: 28249824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and Specific Elimination of EGFR
    Bauerschlag D; Meinhold-Heerlein I; Maass N; Bleilevens A; Bräutigam K; Al Rawashdeh W; Di Fiore S; Haugg AM; Gremse F; Steitz J; Fischer R; Stickeler E; Barth S; Hussain AF
    Pharm Res; 2017 Apr; 34(4):696-703. PubMed ID: 28074431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNAP-Tag Technology: A Useful Tool To Determine Affinity Constants and Other Functional Parameters of Novel Antibody Fragments.
    Niesen J; Sack M; Seidel M; Fendel R; Barth S; Fischer R; Stein C
    Bioconjug Chem; 2016 Aug; 27(8):1931-41. PubMed ID: 27391930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
    Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP
    J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment.
    Deng S; Lin Z; Li W
    Curr Med Chem; 2017; 24(23):2505-2527. PubMed ID: 28554322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
    Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
    PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
    Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
    J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells.
    Huysamen AM; Fadeyi OE; Mayuni G; Dogbey DM; Mungra N; Biteghe FAN; Hardcastle N; Ramamurthy D; Akinrinmade OA; Naran K; Cooper S; Lang D; Richter W; Hunter R; Barth S
    ACS Omega; 2023 Jan; 8(4):4026-4037. PubMed ID: 36743041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.